Intratumoral but not systemic delivery of CpG oligodeoxynucleotide augments the efficacy of anti-CD20 monoclonal antibody therapy against B cell lymphoma (Q39844721)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Intratumoral but not systemic delivery of CpG oligodeoxynucleotide augments the efficacy of anti-CD20 monoclonal antibody therapy against B cell lymphoma
scientific article

    Statements

    Intratumoral but not systemic delivery of CpG oligodeoxynucleotide augments the efficacy of anti-CD20 monoclonal antibody therapy against B cell lymphoma (English)
    David J Betting
    Reiko E Yamada
    Kamran Kafi
    Jonathan Said
    John M Timmerman
    1 July 2009
    622-631

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit